Citations (88)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Lilit Karapetyan, Jason J Luke & Diwakar Davar. (2020) Toll-Like Receptor 9 Agonists in Cancer. OncoTargets and Therapy 13, pages 10039-10060.
Read now
Read now
Adrian Pelin, Stephen Boulton, Levi A. Tamming, John C. Bell & Ragunath Singaravelu. (2020) Engineering vaccinia virus as an immunotherapeutic battleship to overcome tumor heterogeneity. Expert Opinion on Biological Therapy 20:9, pages 1083-1097.
Read now
Read now
Lin-ang Wang, Bo Yang, Wen Rao, Hualiang Xiao, Dong Wang & Jun Jiang. (2019) The correlation of BER protein, IRF3 with CD8+ T cell and their prognostic significance in upper tract urothelial carcinoma. OncoTargets and Therapy 12, pages 7725-7735.
Read now
Read now
Shashi Gujar, Jonathan G. Pol & Guido Kroemer. (2018) Heating it up: Oncolytic viruses make tumors ‘hot’ and suitable for checkpoint blockade immunotherapies. OncoImmunology 7:8.
Read now
Read now
Articles from other publishers (84)
Sandra Van Lint, Alexander Van Parys, Bram Van Den Eeckhout, Niels Vandamme, Stephane Plaisance, Annick Verhee, Dominiek Catteeuw, Elke Rogge, Jennifer De Geest, Nele Vanderroost, Jana Roels, Yvan Saeys, Gilles Uzé, Niko Kley, Anje Cauwels & Jan Tavernier. (2023) A bispecific Clec9A-PD-L1 targeted type I interferon profoundly reshapes the tumor microenvironment towards an antitumor state. Molecular Cancer 22:1.
Crossref
Crossref
Lena Hänsch, Matthias Peipp, Maximilian Mastall, Danielle Villars, Renier Myburgh, Manuela Silginer, Tobias Weiss, Dorothee Gramatzki, Flavio Vasella, Markus G Manz, Michael Weller & Patrick Roth. (2023) Chimeric antigen receptor T cell-based targeting of CD317 as a novel immunotherapeutic strategy against glioblastoma. Neuro-Oncology 25:11, pages 2001-2014.
Crossref
Crossref
Taylor P. Uccello, Maggie L. Lesch, Sarah A. Kintzel, Lauren B. Gradzewicz, Lillia Lamrous, Shawn P. Murphy, Fergal J. Fleming, Bradley N. Mills, Joseph D. Murphy, Angela Hughson, Gary Hannon, Jesse Garrett-Larsen, Haoming Qiu, Michael G. Drage, Jian Ye, Nicholas W. Gavras, David C. Keeley, Tanzy M. T. Love, Elizabeth A. Repasky, Edith M. Lord, David C. Linehan & Scott A. Gerber. (2023) New insights into the responder/nonresponder divide in rectal cancer: Damage-induced Type I IFNs dictate treatment efficacy and can be targeted to enhance radiotherapy. Cell Death & Disease 14:7.
Crossref
Crossref
Morten Frier Gjerstorff. (2023) Crosstalk between interferon and interleukin-1 antiviral signaling in cancer cells: implications for immune evasion and therapeutic resistance. Frontiers in Immunology 14.
Crossref
Crossref
Weili Ma, Maria Cecília Oliveira-Nunes, Ke Xu, Andrew Kossenkov, Benjamin C. Reiner, Richard C. Crist, James Hayden & Qing Chen. (2023) Type I interferon response in astrocytes promotes brain metastasis by enhancing monocytic myeloid cell recruitment. Nature Communications 14:1.
Crossref
Crossref
Priya Saikumar Lakshmi, Cliff I Oduor, Catherine S Forconi, Viriato M’Bana, Courtney Bly, Rachel M Gerstein, Juliana A Otieno, John M Ong’echa, Christian Münz, Micah A Luftig, Michael A Brehm, Jeffrey A Bailey & Ann M Moormann. (2023) Endemic Burkitt lymphoma avatar mouse models for exploring inter-patient tumor variation and testing targeted therapies. Life Science Alliance 6:5, pages e202101355.
Crossref
Crossref
Jiahao Zhu, Jie Lian, Benjie Xu, Xiangyi Pang, Shengjun Ji, Yutian Zhao & Haibo Lu. (2023) Neoadjuvant immunotherapy for colorectal cancer: Right regimens, right patients, right directions?. Frontiers in Immunology 14.
Crossref
Crossref
Cindy Barba, H. Atakan Ekiz, William Weihao Tang, Arevik Ghazaryan, Mason Hansen, Soh-Hyun Lee, Warren Peter Voth & Ryan Michael O’Connell. (2023) Interferon Gamma-Inducible NAMPT in Melanoma Cells Serves as a Mechanism of Resistance to Enhance Tumor Growth. Cancers 15:5, pages 1411.
Crossref
Crossref
Nicole Hardy, Charan Thej Reddy Vegivinti, Mansi Mehta, Jade Thurnham, Alexander Mebane, John M. Pederson, Ranita Tarchand, Jeevan Shivakumar, Peace Olaniran, Ritika Gadodia, Arup Ganguly, Yashaswini Kelagere, Rashmika Reddy Nallabolu, Mrunanjali Gaddam, Praneeth R. Keesari, Yashwitha Sai Pulakurthi, Rohit Reddy, Kevin Kallmes & Tejo N. Musunuru. (2023) Mortality of COVID-19 in patients with hematological malignancies versus solid tumors: a systematic literature review and meta-analysis. Clinical and Experimental Medicine.
Crossref
Crossref
Laura C Van Eyndhoven, Vincent PG Verberne, Carlijn VC Bouten, Abhyudai Singh & Jurjen Tel. (2023) Transiently heritable fates and quorum sensing drive early IFN-I response dynamics. eLife 12.
Crossref
Crossref
Kenneth Lundstrom, Altijana Hromić-Jahjefendić, Esma Bilajac, Alaa A.A. Aljabali, Katarina Baralić, Nagwa A. Sabri, Eslam M. Shehata, Mohamed Raslan, Ana Cláudia B.H. Ferreira, Lidiane Orlandi, Ángel Serrano-Aroca, Murtaza M. Tambuwala, Vladimir N. Uversky, Vasco Azevedo, Khalid J. Alzahrani, Khalaf F. Alsharif, Ibrahim F. Halawani, Fuad M. Alzahrani, Elrashdy M. Redwan & Debmalya Barh. (2023) COVID-19 signalome: Pathways for SARS-CoV-2 infection and impact on COVID-19 associated comorbidity. Cellular Signalling 101, pages 110495.
Crossref
Crossref
Sofie Traynor, Mikkel Green Terp, Aaraby Yoheswaran Nielsen, Per Guldberg, Mie Jakobsen, Pernille Gejl Pedersen, Odd Lilleng Gammelgaard, Christina Bøg Pedersen, Mathilde Thybo Pedersen, Sofie Rattenborg, Henrik Jørn Ditzel & Morten Frier Gjerstorff. (2023) DNA methyltransferase inhibition promotes recruitment of myeloid-derived suppressor cells to the tumor microenvironment through induction of tumor cell-intrinsic interleukin-1. Cancer Letters 552, pages 215982.
Crossref
Crossref
Xiaodan Yang, Xiaosong Liu, Junjie Li, Pingping Zhang, Hejie Li, Guoqiang Chen, Wei Zhang, Tianfang Wang, Ian Frazer & Guoying Ni. (2022) Caerin 1.1/1.9 Enhances Antitumour Immunity by Activating the IFN-α Response Signalling Pathway of Tumour Macrophages. Cancers 14:23, pages 5785.
Crossref
Crossref
Jose A. Costoya & Victor M. Arce. (2022) Cancer cells escape the immune system by increasing stemness through epigenetic reprogramming. Cellular & Molecular Immunology 20:1, pages 6-7.
Crossref
Crossref
Zdeněk Vavřina, Pavla Perlíková, Nemanja Milisavljević, Florian Chevrier, Miroslav Smola, Joshua Smith, Milan Dejmek, Vojtěch Havlíček, Miloš Buděšínský, Radek Liboska, Lenka Vaneková, Jiří Brynda, Evzen Boura, Pavlína Řezáčová, Michal Hocek & Gabriel Birkuš. (2022) Design, Synthesis, and Biochemical and Biological Evaluation of Novel 7-Deazapurine Cyclic Dinucleotide Analogues as STING Receptor Agonists. Journal of Medicinal Chemistry 65:20, pages 14082-14103.
Crossref
Crossref
Letizia Vitali, Alessandra Merlini, Federica Galvagno, Alessia Proment & Dario Sangiolo. (2022) Biological and Exploitable Crossroads for the Immune Response in Cancer and COVID-19. Biomedicines 10:10, pages 2628.
Crossref
Crossref
Emi A. Lutz, Yash Agarwal, Noor Momin, Sarah C. Cowles, Joseph R. Palmeri, Ellen Duong, Vladlena Hornet, Allison Sheen, Brianna M. Lax, Adrienne M. Rothschilds, Darrell J. Irvine, Stefani Spranger & K. Dane Wittrup. (2022) Alum-anchored intratumoral retention improves the tolerability and antitumor efficacy of type I interferon therapies. Proceedings of the National Academy of Sciences 119:36.
Crossref
Crossref
Martina Musella, Andrea Guarracino, Nicoletta Manduca, Claudia Galassi, Eliana Ruggiero, Alessia Potenza, Ester Maccafeo, Gwenola Manic, Luca Mattiello, Sara Soliman Abdel Rehim, Michele Signore, Marco Pietrosanto, Manuela Helmer-Citterich, Matteo Pallocca, Maurizio Fanciulli, Tiziana Bruno, Francesca De Nicola, Giacomo Corleone, Anna Di Benedetto, Cristiana Ercolani, Edoardo Pescarmona, Laura Pizzuti, Francesco Guidi, Francesca Sperati, Sara Vitale, Daniele Macchia, Massimo Spada, Giovanna Schiavoni, Fabrizio Mattei, Adele De Ninno, Luca Businaro, Valeria Lucarini, Laura Bracci, Eleonora Aricò, Giovanna Ziccheddu, Francesco Facchiano, Stefania Rossi, Massimo Sanchez, Alessandra Boe, Mauro Biffoni, Ruggero De Maria, Ilio Vitale & Antonella Sistigu. (2022) Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B. Nature Immunology 23:9, pages 1379-1392.
Crossref
Crossref
Jason P. Lynch, Lisa Goers & Cammie F. Lesser. (2022) Emerging strategies for engineering Escherichia coli Nissle 1917-based therapeutics. Trends in Pharmacological Sciences 43:9, pages 772-786.
Crossref
Crossref
Ashish Kumar Mishra, Siddharth Kumar Singh, Sruthilaya Dayanandan, Smaran Banerjee, Soumyadeep Chakraborty, Akshita Baiju Gopal, Supriya Samal, Indrajit Poirah, Debashish Chakraborty & Asima Bhattacharyya. (2022) Hypoxia-driven metabolic heterogeneity and immune evasive behaviour of gastrointestinal cancers: Elements of a recipe for disaster. Cytokine 156, pages 155917.
Crossref
Crossref
Jiepin Wang, Dong Xiao & Junxiang Wang. (2022) A 16-miRNA Prognostic Model to Predict Overall Survival in Neuroblastoma. Frontiers in Genetics 13.
Crossref
Crossref
Nader El-Sayes, Scott Walsh, Alyssa Vito, Amir Reihani, Kjetil Ask, Yonghong Wan & Karen Mossman. (2022) IFNAR blockade synergizes with oncolytic VSV to prevent virus-mediated PD-L1 expression and promote antitumor T cell activity. Molecular Therapy - Oncolytics 25, pages 16-30.
Crossref
Crossref
Stephanie Seneff, Greg Nigh, Anthony M. Kyriakopoulos & Peter A. McCullough. (2022) Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs. Food and Chemical Toxicology 164, pages 113008.
Crossref
Crossref
Na-Lee Ka, Ga Young Lim, Seung‑Su Kim, Sewon Hwang, Juhyeong Han, Yun-Hee Lee & Mi-Ock Lee. (2022) Type I IFN stimulates IFI16-mediated aromatase expression in adipocytes that promotes E2-dependent growth of ER-positive breast cancer. Cellular and Molecular Life Sciences 79:6.
Crossref
Crossref
Bingrui Wang, Chenchen Wang, Yang Wan, Jie Gao, Yige Ma, Yingnan Zhang, Jingyuan Tong, Yingchi Zhang, Jinhua Liu, Lixian Chang, Changlu Xu, Biao Shen, Yumei Chen, Erlie Jiang, Ryo Kurita, Yukio Nakamura, Kim-Chew Lim, James Douglas Engel, Jiaxi Zhou, Tao Cheng, Xiaofan Zhu, Ping Zhu & Lihong Shi. (2022) Decoding the pathogenesis of Diamond–Blackfan anemia using single-cell RNA-seq. Cell Discovery 8:1.
Crossref
Crossref
Tomokazu S. Sumida, Shai Dulberg, Jonas C. Schupp, Matthew R. Lincoln, Helen A. Stillwell, Pierre-Paul Axisa, Michela Comi, Avraham Unterman, Naftali Kaminski, Asaf Madi, Vijay K. Kuchroo & David A. Hafler. (2022) Type I interferon transcriptional network regulates expression of coinhibitory receptors in human T cells. Nature Immunology 23:4, pages 632-642.
Crossref
Crossref
Ryan A. Hlady, Xia Zhao, Louis Y. El Khoury, Aesis Luna, Kien Pham, Qunfeng Wu, Jeong‐Heon Lee, Nikolaos T. Pyrsopoulos, Chen Liu & Keith D. Robertson. (2021) Interferon drives HCV scarring of the epigenome and creates targetable vulnerabilities following viral clearance. Hepatology 75:4, pages 983-996.
Crossref
Crossref
Fawen Dai, Yanting Liu, Meimei Zhang, Tao Lin, Huashuo Chu, Ruixue Gong & Baokai Zhao. (2022) Effects from Oral Administration of Recombinant Interferon-Alpha on Piglet Daily Care. Mobile Information Systems 2022, pages 1-6.
Crossref
Crossref
Yusuke Tamura, Shuichi Tsutsumi, Kohei Miyazono & Daizo Koinuma. (2021) PolyI:C attenuates transforming growth factor‐β signaling to induce cytostasis of surrounding cells by secreted factors in triple‐negative breast cancer. Cancer Science 113:3, pages 940-949.
Crossref
Crossref
Patrick O'Connell, Maja K. Blake, Yuliya Pepelyayeva, Sean Hyslop, Sarah Godbehere, Ariana M. Angarita, Cristiane Pereira-Hicks, Andrea Amalfitano & Yasser A. Aldhamen. (2022) Adenoviral delivery of an immunomodulatory protein to the tumor microenvironment controls tumor growth. Molecular Therapy - Oncolytics 24, pages 180-193.
Crossref
Crossref
Dakota W. Goad, Christian Bressy, Molly C. Holbrook & Valery Z. Grdzelishvili. (2022) Acquired chemoresistance can lead to increased resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus. Molecular Therapy - Oncolytics 24, pages 59-76.
Crossref
Crossref
Carlotta Cattolico, Peter Bailey & Simon T. Barry. (2022) Modulation of Type I Interferon Responses to Influence Tumor-Immune Cross Talk in PDAC. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Ellen Duong, Tim B. Fessenden, Emi Lutz, Teresa Dinter, Leon Yim, Sarah Blatt, Arjun Bhutkar, Karl Dane Wittrup & Stefani Spranger. (2022) Type I interferon activates MHC class I-dressed CD11b+ conventional dendritic cells to promote protective anti-tumor CD8+ T cell immunity. Immunity 55:2, pages 308-323.e9.
Crossref
Crossref
Jasmine J M Chuah, Paul J Hertzog & Nicole K Campbell. (2022) Immunoregulation by type I interferons in the peritoneal cavity. Journal of Leukocyte Biology 111:2, pages 337-353.
Crossref
Crossref
Iago Dillion Lima CavalcantiIago Dillion Lima Cavalcanti. 2022. Chemotherapy Protocols and Infusion Sequence. Chemotherapy Protocols and Infusion Sequence
201
231
.
Rodrigo Nalio Ramos, Caroline Tosch, Fiorella Kotsias, Marie‐Christine Claudepierre, Doris Schmitt, Christelle Remy‐Ziller, Chantal Hoffmann, Marine Ricordel, Virginie Nourtier, Isabelle Farine, Laurence Laruelle, Julie Hortelano, Clementine Spring‐Giusti, Christine Sedlik, Christophe Le Tourneau, Caroline Hoffmann, Nathalie Silvestre, Philippe Erbs, Kaidre Bendjama, Christine Thioudellet, Eric Quemeneur, Eliane Piaggio & Karola Rittner. (2022) Pseudocowpox virus, a novel vector to enhance the therapeutic efficacy of antitumor vaccination. Clinical & Translational Immunology 11:5.
Crossref
Crossref
Barbora Novotná, Lucie Holá, Monika Staś, Ondrej Gutten, Miroslav Smola, Martin Zavřel, Zdeněk Vavřina, Miloš Buděšínský, Radek Liboska, Florian Chevrier, Juraj Dobiaš, Evzen Boura, Lubomír Rulíšek & Gabriel Birkuš. (2021) Enzymatic Synthesis of 3′–5′, 3′–5′ Cyclic Dinucleotides, Their Binding Properties to the Stimulator of Interferon Genes Adaptor Protein, and Structure/Activity Correlations. Biochemistry 60:48, pages 3714-3727.
Crossref
Crossref
Sima Chaudhari, Satyajit Dey Pereira, Meshach Asare-Warehene, Ritam Naha, Shama Prasada Kabekkodu, Benjamin K. Tsang & Kapaettu Satyamoorthy. (2021) Comorbidities and inflammation associated with ovarian cancer and its influence on SARS-CoV-2 infection. Journal of Ovarian Research 14:1.
Crossref
Crossref
Zhi Zong, Yujun Wei, Jiang Ren, Long Zhang & Fangfang Zhou. (2021) The intersection of COVID-19 and cancer: signaling pathways and treatment implications. Molecular Cancer 20:1.
Crossref
Crossref
Samantha K. Von Rueden & Timothy M. Fan. (2021) Cancer-Immunity Cycle and Therapeutic Interventions- Opportunities for Including Pet Dogs With Cancer. Frontiers in Oncology 11.
Crossref
Crossref
Xin Zheng, Zijian Liu, Mi Mi, Qiuyue Wen, Gang Wu & Liling Zhang. (2021) Disulfiram Improves the Anti-PD-1 Therapy Efficacy by Regulating PD-L1 Expression via Epigenetically Reactivation of IRF7 in Triple Negative Breast Cancer. Frontiers in Oncology 11.
Crossref
Crossref
Fiona M. Healy, Lekh N. Dahal, Jack R.E. Jones, Yngvar Floisand & John F. Woolley. (2021) Recent Progress in Interferon Therapy for Myeloid Malignancies. Frontiers in Oncology 11.
Crossref
Crossref
Timo Oosenbrug, Diana J.M. van den Wollenberg, Eline W. DuitsRob C. HoebenMaaike E. Ressing. (2021) Induction of Robust Type I Interferon Levels by Oncolytic Reovirus Requires Both Viral Replication and Interferon-α/β Receptor Signaling. Human Gene Therapy 32:19-20, pages 1171-1185.
Crossref
Crossref
Paola Trono, Annalisa Tocci, Martina Musella, Antonella Sistigu & Paola Nisticò. (2021) Actin Cytoskeleton Dynamics and Type I IFN-Mediated Immune Response: A Dangerous Liaison in Cancer?. Biology 10:9, pages 913.
Crossref
Crossref
Martina Musella, Claudia Galassi, Nicoletta Manduca & Antonella Sistigu. (2021) The Yin and Yang of Type I IFNs in Cancer Promotion and Immune Activation. Biology 10:9, pages 856.
Crossref
Crossref
Laura C. Van Eyndhoven, Abhyudai Singh & Jurjen Tel. (2021) Decoding the dynamics of multilayered stochastic antiviral IFN-I responses. Trends in Immunology 42:9, pages 824-839.
Crossref
Crossref
David Hutin, Alexandra S Long, Kim Sugamori, Peng Shao, Sachin Kumar Singh, Marit Rasmussen, Ninni Elise Olafsen, Solveig Pettersen, Giulia Grimaldi, Denis M Grant & Jason Matthews. (2021)
2,3,7,8-Tetrachlorodibenzo-
p
-Dioxin (TCDD)-Inducible Poly-ADP-Ribose Polymerase (TIPARP/PARP7) Catalytic Mutant Mice (
TiparpH532A
) Exhibit Increased Sensitivity to TCDD-Induced Hepatotoxicity and Lethality
. Toxicological Sciences 183:1, pages 154-169.
Crossref
Crossref
Vaishali Chandel & Dhruv Kumar. 2021. Innate Immunity in Health and Disease. Innate Immunity in Health and Disease.
Omar Rabab’h, Abeer Gharaibeh, Ali Al-Ramadan, Manar Ismail & Jawad Shah. (2021) Pharmacological Approaches in Neurofibromatosis Type 1-Associated Nervous System Tumors. Cancers 13:15, pages 3880.
Crossref
Crossref
Emma Saulters, John F. Woolley, Shankar Varadarajan, Terence M. Jones & Lekh N. Dahal. (2021) STINGing Viral Tumors: What We Know from Head and Neck Cancers. Cancer Research 81:15, pages 3945-3952.
Crossref
Crossref
Damien J. Zanker, Katie L. Owen, Nikola Baschuk, Alex J. Spurling & Belinda S. Parker. (2021) Loss of type I IFN responsiveness impairs natural killer cell antitumor activity in breast cancer. Cancer Immunology, Immunotherapy 70:8, pages 2125-2138.
Crossref
Crossref
Klara Klein, Agnieszka Witalisz-Siepracka, Dagmar Gotthardt, Benedikt Agerer, Felix Locker, Reinhard Grausenburger, Vanessa Maria Knab, Andreas Bergthaler & Veronika Sexl. (2021) T Cell-Intrinsic CDK6 Is Dispensable for Anti-Viral and Anti-Tumor Responses In Vivo. Frontiers in Immunology 12.
Crossref
Crossref
Ebunoluwa E. Otegbeye, Jonathan B. Mitchem, Haeseong Park, Aadel A. Chaudhuri, Hyun Kim, Matthew G. Mutch & Matthew A. Ciorba. (2021) Immunity, immunotherapy, and rectal cancer: A clinical and translational science review. Translational Research 231, pages 124-138.
Crossref
Crossref
Ondrej Gutten, Petr Jurečka, Zahra Aliakbar Tehrani, Miloš Buděšínský, Jan Řezáč & Lubomír Rulíšek. (2021)
Conformational energies and equilibria of cyclic dinucleotides
in vacuo
and in solution: computational chemistry
vs.
NMR experiments
. Physical Chemistry Chemical Physics 23:12, pages 7280-7294.
Crossref
Crossref
Benedetta Apollonio, Nikolaos Ioannou, Despoina Papazoglou & Alan G. Ramsay. (2021) Understanding the Immune-Stroma Microenvironment in B Cell Malignancies for Effective Immunotherapy. Frontiers in Oncology 11.
Crossref
Crossref
Zhen Zeng, Hui Yi Chew, Jazmina G. Cruz, Graham R. Leggatt & James W. Wells. (2021) Investigating T Cell Immunity in Cancer: Achievements and Prospects. International Journal of Molecular Sciences 22:6, pages 2907.
Crossref
Crossref
Akhil Shukla, Maryse Cloutier, Madanraj Appiya Santharam, Sheela Ramanathan & Subburaj Ilangumaran. (2021) The MHC Class-I Transactivator NLRC5: Implications to Cancer Immunology and Potential Applications to Cancer Immunotherapy. International Journal of Molecular Sciences 22:4, pages 1964.
Crossref
Crossref
Zhiying Huang & Haifeng Hu. (2021) Arginine Deiminase Induces Immunogenic Cell Death and Is Enhanced by N-acetylcysteine in Murine MC38 Colorectal Cancer Cells and MDA-MB-231 Human Breast Cancer Cells In Vitro. Molecules 26:2, pages 511.
Crossref
Crossref
Sandra Gessani & Filippo Belardelli. (2021) Type I Interferons as Joint Regulators of Tumor Growth and Obesity. Cancers 13:2, pages 196.
Crossref
Crossref
Anil Kumar, Adeleh Taghi Khani & Srividya Swaminathan. (2021) Type I interferons: One stone to concurrently kill two birds, viral infections and cancers. Current Research in Virological Science 2, pages 100014.
Crossref
Crossref
Carolina Mendonça Gorgulho, Graziela Gorete Romagnoli & Ramon Kaneno. 2021. Cancer Immunology. Cancer Immunology
183
197
.
Sahel Sarabandi, Shima Karami, Mehrdad Heravi, Farhad Tabasi, Mohammad Hashemi & Gholamreza Bahari. (2020) Deletion allele of IFNAR1 gene polymorphism (rs17875871) is associated with a lower risk of breast cancer: A preliminary report. Meta Gene 26, pages 100760.
Crossref
Crossref
Jonathan G. Pol, Samuel T. Workenhe, Prathyusha Konda, Shashi Gujar & Guido Kroemer. (2020) Cytokines in oncolytic virotherapy. Cytokine & Growth Factor Reviews 56, pages 4-27.
Crossref
Crossref
Yingying Han, Arnaud Huard, Javier Mora, Priscila da Silva, Bernhard Brüne & Andreas Weigert. (2020) IL-36 family cytokines in protective versus destructive inflammation. Cellular Signalling 75, pages 109773.
Crossref
Crossref
Lisa Derosa, Cléa Melenotte, Franck Griscelli, Bertrand Gachot, Aurélien Marabelle, Guido Kroemer & Laurence Zitvogel. (2020) The immuno-oncological challenge of COVID-19. Nature Cancer 1:10, pages 946-964.
Crossref
Crossref
Bo Yang, Wen Rao, Hao Luo, Liang Zhang & Dong Wang. (2020) Relapse‐related molecular signature in early‐stage lung adenocarcinomas based on base excision repair, stimulator of interferon genes pathway and tumor‐infiltrating lymphocytes. Cancer Science 111:10, pages 3493-3502.
Crossref
Crossref
Jorn E. Stok, M. Eloisa Vega Quiroz & Annemarthe G. van der Veen. (2020) Self RNA Sensing by RIG-I–like Receptors in Viral Infection and Sterile Inflammation. The Journal of Immunology 205:4, pages 883-891.
Crossref
Crossref
Wook Jin. (2020) The Role of Tyrosine Kinases as a Critical Prognostic Parameter and Its Targeted Therapies in Ewing Sarcoma. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Annelisa M. Cornel, Iris L. Mimpen & Stefan Nierkens. (2020) MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy. Cancers 12:7, pages 1760.
Crossref
Crossref
Anthony C. Buzzai, Teagan Wagner, Katherine M. Audsley, Hannah V. Newnes, Lucy W. Barrett, Samantha Barnes, Ben C. Wylie, Shane Stone, Alison McDonnell, Vanessa S. Fear, Bree Foley & Jason Waithman. (2020) Diverse Anti-Tumor Immune Potential Driven by Individual IFNα Subtypes. Frontiers in Immunology 11.
Crossref
Crossref
Yesim Ozguler, Gulen Hatemi, Firat Cetinkaya, Koray Tascilar, Vedat Hamuryudan, Serdal Ugurlu, Emire Seyahi, Hasan Yazici & Melike Melikoglu. (2020) Clinical course of acute deep vein thrombosis of the legs in Behçet’s syndrome. Rheumatology 59:4, pages 799-806.
Crossref
Crossref
Faya Zhang, Subrata Manna, Laurentiu M. Pop, Zhijian J. Chen, Yang-Xin Fu & Raquibul Hannan. (2020) Type I Interferon Response in Radiation-Induced Anti-Tumor Immunity. Seminars in Radiation Oncology 30:2, pages 129-138.
Crossref
Crossref
Marie-Eve Charbonneau & Mary X.D. O’Riordan. (2020) Reducing Stress PERKs up Anti-tumor Immunity. Immunity 52:4, pages 575-577.
Crossref
Crossref
Tiziana Di Marco, Francesca Bianchi, Lucia Sfondrini, Katia Todoerti, Italia Bongarzone, Elisa Margherita Maffioli, Gabriella Tedeschi, Mara Mazzoni, Sonia Pagliardini, Sandra Pellegrini, Antonino Neri, Maria Chiara Anania & Angela Greco. (2020) COPZ1 depletion in thyroid tumor cells triggers type I IFN response and immunogenic cell death. Cancer Letters 476, pages 106-119.
Crossref
Crossref
Sara Saab, Hussein Zalzale, Zahraa Rahal, Yara Khalifeh, Ansam Sinjab & Humam Kadara. (2020) Insights Into Lung Cancer Immune-Based Biology, Prevention, and Treatment. Frontiers in Immunology 11.
Crossref
Crossref
Anzhelika Karjalainen, Stephen Shoebridge, Milica Krunic, Natalija Simonović, Graham Tebb, Sabine Macho-Maschler, Birgit Strobl & Mathias Müller. (2020) TYK2 in Tumor Immunosurveillance. Cancers 12:1, pages 150.
Crossref
Crossref
Martina Musella, Gwenola Manic, Claudia Galassi, Ilio Vitale & Antonella Sistigu. 2020. Tumor Immunology and Immunotherapy – Cellular Methods Part B. Tumor Immunology and Immunotherapy – Cellular Methods Part B
39
54
.
Barbora Novotná, Lenka Vaneková, Martin Zavřel, Miloš Buděšínský, Milan Dejmek, Miroslav Smola, Ondrej Gutten, Zahra Aliakbar Tehrani, Markéta Pimková Polidarová, Andrea Brázdová, Radek Liboska, Ivan Štěpánek, Zdeněk Vavřina, Tomáš Jandušík, Radim Nencka, Lubomír Rulíšek, Evžen Bouřa, Jiří Brynda, Ondřej Páv & Gabriel Birkuš. (2019) Enzymatic Preparation of 2′–5′,3′–5′-Cyclic Dinucleotides, Their Binding Properties to Stimulator of Interferon Genes Adaptor Protein, and Structure/Activity Correlations. Journal of Medicinal Chemistry 62:23, pages 10676-10690.
Crossref
Crossref
María Julia Lamberti, Fátima María Mentucci, Emiliano Roselli, Paula Araya, Viviana Alicia Rivarola, Natalia Belén Rumie Vittar & Mariana Maccioni. (2019) Photodynamic Modulation of Type 1 Interferon Pathway on Melanoma Cells Promotes Dendritic Cell Activation. Frontiers in Immunology 10.
Crossref
Crossref
Ekaterina Pylaeva, Sharareh Bordbari, Ilona Spyra, Anna Sophie Decker, Susanne Häussler, Vadim Vybornov, Stephan Lang & Jadwiga Jablonska. (2019) Detrimental Effect of Type I IFNs During Acute Lung Infection With Pseudomonas aeruginosa Is Mediated Through the Stimulation of Neutrophil NETosis. Frontiers in Immunology 10.
Crossref
Crossref
Marion V. Guerin, Fabienne Regnier, Vincent Feuillet, Lene Vimeux, Julia M. Weiss, Georges Bismuth, Gregoire Altan-Bonnet, Thomas Guilbert, Maxime Thoreau, Veronica Finisguerra, Emmanuel Donnadieu, Alain Trautmann & Nadège Bercovici. (2019) TGFβ blocks IFNα/β release and tumor rejection in spontaneous mammary tumors. Nature Communications 10:1.
Crossref
Crossref
Anoop Singh Chauhan, Li Zhuang & Boyi Gan. (2019) Antagonism between Antiviral Signaling and Glycolysis. Trends in Endocrinology & Metabolism 30:9, pages 571-573.
Crossref
Crossref
Ondrej Palata, Nada Hradilova Podzimkova, Eva Nedvedova, Alexandra Umprecht, Lenka Sadilkova, Lenka Palova Jelinkova, Radek Spisek & Irena Adkins. (2019) Radiotherapy in Combination With Cytokine Treatment. Frontiers in Oncology 9.
Crossref
Crossref
Olga Kurmyshkina, Pavel Kovchur, Ludmila Schegoleva & Tatyana Volkova. 2018. Cervical Cancer - Screening, Treatment and Prevention - Universal Protocols for Ultimate Control. Cervical Cancer - Screening, Treatment and Prevention - Universal Protocols for Ultimate Control.